RE:RE:RE:Accelerated ApprovalsRight. I think we're already on track for AA for the current trial for bcg unresponsive NMIBC. But with this new program, with already demonstrated safety and recognized "surrogate endpoints" (read early indications of efficacy) just around the corner plus the bcg shortage, maybe we could also get early approval as a front line treatment.
gojotv! wrote: No kidding!
The industry is just knocking down so many little regulatory walls that stood in our way!
Imagine the value of being the first-line treatment for NMIBC instead of waiting for BCG to have been tried and failed!
charlierock wrote: Project Front Runner to come on line later this year.... That's great news and right up our alley.
The timing couldn't be better!!